Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure

Hypertension

Volumn 30, Issue 1, 1997, Pages 50-56

  Mohri, Masahiro ^a   Egashira, Kensuke ^a   Tagawa, Tatsuya ^a   Kuga, Takeshi ^a   Tagawa, Hirofumi ^a   Harasawa, Yasuhiko ^a   Shimokawa, Hiroaki ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy, congestive; Congestive; Coronary circulation; Heart failure; Heart valve diseases; Nitric oxide

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL;

EID: 0030802280     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.50     Document Type: Article

References (34)

1. Kiowski W. Endothelial function in humans: studies of forearm resistance vessels. Hypertension. 1991;18(suppl II):II-84-II-89.
2. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
3. Shimokawa H, Takeshita A. Endothelium-dependent regulation of the cardiovascular system. Intern Med. 1995;34:939-946.
4. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction of serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519-2524.
5. Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res. 1994;74:416-421.
6. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JG. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet. 1994; 344:371-373.
7. Kubo SH, Rector TS, Bank AJ, Raij L, Kraemer MD, Tadros P, Beardslee M, Garr MD. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol. 1994;74: 1133-1136.
8. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596-1601.
9. O'Murchu B, Miller VM, Perrella MA, Burnett JCJ. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest. 1994;93:165-171.
10. Drexler H, Hablawetz E, Wenyan L, Riede U, Christas A. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation. 1992;86:255-262.
11. Wang J, Seyedi N, Xu X-B, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol. 1994;266:H670-H680.
12. Borow KM, Green LH, Mann T, Sloss LJ, Braunwald E, Collins JJ Jr, Cohn L, Grossman W. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Cardiol. 1980;68:655-663.
13. Boucher CA, Bingham JB, Osbakken MD, Okada RD, Strauss HW, Block PC, Levine FH, Phillips HR, Pohost GM. Early changes in left ventricular size and function after correction of left ventricular volume overload. Am J Cardiol. 1981;47:991-1004.
14. Harasawa Y, Yoshida T, Sunagawa K, Takeshita A. A novel index of left ventricular systolic function that is less afterload-dependent than ejection fraction. Heart Vessels. 1992;suppl 8:15. Abstract.
15. McKay RG, Aroesty JM, Heller GV, Royal HD, Warren SE, Grossman W. Assessment of the end-systolic pressure-volume relationship in human beings with the use of a time-varying elastance model. Circulation. 1986;74:97-104.
16. Sagawa K. The ventricular pressure-volume diagram revisited. Circ Res. 1978;43:677-687.
17. Tschudi M, Richard V, Bühler FR. Lüscher TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol. 1991;260:H13-H20.
18. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilation induced by pacing tachycardia in humans. Circ Res. 1996;79:331-335.
19. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659-1664.
20. Kuga T, Egashira K, Mohri M. Tsutsui H, Harasawa Y, Urabe Y, Ando S, Shimokawa H, Takeshita A. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation. 1995; 92:183-189.
21. Egashira K. Katsuda Y. Mohri M, Kuga T. Tagawa T. Shimokawa H, Takeshita A. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 1996;27:1444-1449.
22. Doucette JW, Corl PD, Payne MH, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85: 1899-1911.
23. Zhao G, Shen W, Xu X, Ochoa M, Bernstein R, Hintze TH. Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. Circulation. 1995;91:2655-2663.
24. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93: 1087-1094.
25. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Cannon RO. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995;95:1747-1755.
26. Antony I, Lerebours G, Nitenberg A. Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation. 1995;91:1624-1628.
27. Kichuk MR, Seyedi N, Zhang X, Marboe CC, Michler RE, Addonizio LJ, Kaley G, Nasjletti A, Hintze TH. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation. 1996;94:44-51.
28. Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 1994;89:375-384.
29. Teerlink JR, Gray GA, Clozel M, Clozel JP. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent: dissociation of basal and stimulated nitric oxide release. Circulation. 1994;89:393-401.
30. Forster C, Campbell PM, Armstrong PW. Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing-induced heart failure. J Cardiovasc Pharmacol. 1992;20:206-215.
31. Woolfson RG, Poston L. Effect of ouabain on endothelium-dependent relaxation of human resistance arteries. Hypertension. 1991;17:619-625.
32. Chen G, Hashitani H, Suzuki H. Endothelium-dependent relaxation and hyperpolarization of canine coronary artery smooth muscles in relation to the electrogenic Na-K pump. Br J Pharmacol. 1989;98:950-956.
33. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, St John Sutton MG, Selwyn AP, Alexander RW, Ganz P. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81: 772-779.
34. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamaguchi H, Kakoi H, Takabatake Y. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J. 1994;127:376-381.